GVR Report cover Peptide Microarray Market Size, Share & Trends Report

Peptide Microarray Market Size, Share & Trends Analysis Report By Product (Instruments, Reagents And Services) By Application, By End-user, By Region, And Segment Forecasts, 2023 To 2030

  • Report ID: GVR453674
  • Number of Pages: 0
  • Format: Electronic (PDF)

Peptide Microarray also known as a peptide epitope microarray are the peptides present on the surface of the plastic chip. These plastic chips, also referred to as peptide chips are used to study the binding mechanism and kinetics of the protein-protein interaction. It is the technology that involves high throughput methods in the field of proteomics and clinical assays. Peptide microarray can be analyzed using mass spectrometry, spectroscopy, and imaging via fluorescence. It has a wide range of applications in the field of pharmacology, medicine, and biology.

It is one of the automated advanced technology to collect large data from a single experiment used for disease diagnosis, therapeutic discoveries, and diagnostic techniques development. The technique is used to identify new drug targets. To locate the antigen, present on the protein surface of bacteria, immunogenic Identification, determination of Abs, mapping of the epitope, enzyme characterization, biomarker validation, serum profiling, and HLA profiling are some of the applications of the peptide microarray. Following are the advantages of peptide microarrays:

  • Cost-effective

  • Flexible design of the sequence of the peptides

  • High batch-to-batch reproducibility

  • Extended shelf strength

In recent years, with the increase in the prevalence of chronic diseases, there is an increase in the demand for molecular diagnostic techniques. Moreover, peptide microarray diagnostic techniques are cost-effective and economical which drives the market. In January 2020, the company named PEPperPRINT launched the proteome-wide peptide microarray which includes COVID-19 2019-nCoV coronavirus. It is used to detect and locate the IgG and IgM Abs present in the patient serum. This is done for the diagnostic tests for vaccine production. This is one of the drivers to accelerate the market forecast.

The key players are also investing in R&D to develop solutions and products for the early diagnosis and treatment of chronic disease. Thus, companies are adopting the advanced technologies of microarray which drives the global microarray market. Moreover, the lack of technical complications in the microarray technology can be a restraining factor.

The market is segmented based on product, application, end-user, and region. The product segment is classified into instruments, reagents, and services. The application segment is segmented into therapeutic vaccine production, proteomics, diagnostics, protein functional analysis, and antibody characterization. The end-user segment is further segmented into pharmaceutical and biotechnology companies, hospitals and clinics, diagnostic centers, and private laboratories.

Based on the regions the market is segmented into North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa. North America dominates the market. The large share is mainly attributed to the developed healthcare facilities in this region along with increasing expenditure in the R&D sector. Also, there is awareness among healthcare workers and people with early diagnosis and treatment of chronic disease which accelerates the diagnostic capabilities in this region and boosts the market. The majority of key players are also present in North America which fuels the market growth.








Therapeutic Vaccine Production,

Disease Diagnostics,

Protein Functional Analysis,

Antibody Characterization


Pharmaceutical and Biotechnology Companies,

Hospitals and Clinics,

Diagnostic Centers,



North America (U.S., Canada),

Europe (Germany, France, Italy, Spain, UK),

Asia Pacific (Japan, China, India, South Korea, Australia),

Latin America (Mexico, Brazil, Argentina),

Middle East & Africa (Saudi Arabia, South Africa, UAE)


Major companies operating in the peptide microarray market include Grace Bio-Labs, Merck KGaA, Creative Biolabs, Thermo Fisher Scientific, Inc., Terra Universal Inc., ProImmune Ltd., LC Sciences, Bio-Rad Laboratories, JPT Peptide Technologies, PEPperPRINT among others.

gvr icn


gvr icn

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

gvr icn


We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

Contact us now to get our best pricing.

esomar icon

ESOMAR certified & member

D&B icon

Leading SME award by D&B

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.

great place to work icon